Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/127625
Title: | Role of NADPH oxidases in the redox biology of liver fibrosis |
Author: | Crosas Molist, Eva Fabregat Romero, Isabel |
Keywords: | Malalties del fetge Liver diseases |
Issue Date: | Dec-2015 |
Publisher: | Elsevier B.V. |
Abstract: | Liver fibrosis is the pathological consequence of chronic liver diseases, where an excessive deposition of extracellular matrix (ECM) proteins occurs, concomitantly with the processes of repair and regeneration. It is characterized by increased production of matrix proteins, in particular collagens, and decreased matrix remodelling. The principal source of ECM accumulation is myofibroblasts (MFB). Most fibrogenic MFB are endogenous to the liver, coming from hepatic stellate cells (HSC) and portal fibroblasts. Dysregulated inflammatory responses have been associated with most (if not all) hepatotoxic insults and chronic oxidative stress play a role during the initial liver inflammatory phase and its progression to fibrosis. Redox-regulated processes are responsible for activation of HSC to MFB, as well as maintenance of the MFB function. Increased oxidative stress also induces hepatocyte apoptosis, which contributes to increase the liver injury and to transdifferentiate HSC to MFB, favouring the fibrogenic process. Mitochondria and other redox-active enzymes can generate superoxide and hydrogen peroxide as a by-product in liver cells. Moreover, accumulating evidence indicates that NADPH oxidases (NOXs), which play a critical role in the inflammatory response, may contribute to reactive oxygen species (ROS) production during liver fibrosis, being important players in HSC activation and hepatocyte apoptosis. Based on the knowledge of the pathogenic role of ROS, different strategies to prevent or reverse the oxidative damage have been developed to be used as therapeutic tools in liver fibrosis. This review will update all these concepts, highlighting the relevance of redox biology in chronic fibrogenic liver pathologies. |
Note: | Versió postprint del document publicat a: https://doi.org/10.1016/j.redox.2015.07.005 |
It is part of: | Redox Biology, 2015, vol. 6, p. 106-111 |
URI: | http://hdl.handle.net/2445/127625 |
Related resource: | https://doi.org/10.1016/j.redox.2015.07.005 |
ISSN: | 2213-2317 |
Appears in Collections: | Articles publicats en revistes (Ciències Fisiològiques) Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)) Publicacions de projectes de recerca finançats per la UE |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
657832.pdf | 898.62 kB | Adobe PDF | View/Open |
This item is licensed under a
Creative Commons License